272586
Community Priority Setting and Selection of Evidence-Based Interventions
Tuesday, October 30, 2012
: 9:00 AM - 9:15 AM
Cancer epidemiology data available through state cancer registries is vital to comprehensive cancer control planning, implementation, and evaluation including assessment of the cancer burden, setting goals and objectives, guiding community priorities and intervention selection, and measuring program impact. This panel session will highlight the systematic process developed by the Kentucky Cancer Registry and Kentucky Cancer Consortium for aggregating cancer epidemiology and sociodemographic data, presenting this data to state and community constituents for intervention planning and evaluation, and how this process influenced colorectal cancer screening, incidence, and mortality rates in Kentucky. This process can be adopted by other state and community organizations to translate cancer epidemiology data into public health practice to reduce the burden of disease. The purpose of this specific presentation is to provide educators, clinicians and public health practitioners with an understanding of the process used to prioritize communities' cancer focus, target population(s), and selection of evidence-based interventions.
Learning Objectives: Attendees will be able to discuss how communities use cancer data to set priorities and chose interventions for cancer control implementation.
Keywords: Cancer, Community Health Planning
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I have practiced in cancer prevention and control research for over 10 years. I serve as Deputy Director of the CDC-funded Rural Cancer Prevention Center; I teach graduate courses in rural health and health promotion. I have partnered with the Kentucky Cancer Consortium and the Kentucky Cancer Registry on several public health initiatives.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|